| Revolutionizing drug formulation development: the increasing impact of machine learning Z Bao, J Bufton, RJ Hickman, A Aspuru-Guzik, P Bannigan, C Allen Advanced Drug Delivery Reviews, 115108, 2023 | 44 | 2023 |
| Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel J Bufton, S Jung, JC Evans, Z Bao, D Aguiar, C Allen European Journal of Pharmaceutical Sciences 162, 105808, 2021 | 10 | 2021 |
| Poly (δ-valerolactone-co-allyl-δ-valerolactone) cross-linked microparticles: Formulation, characterization and biocompatibility Z Bao, S Jung, J Bufton, JC Evans, DJ Aguiar, C Allen Journal of Pharmaceutical Sciences 110 (7), 2771-2777, 2021 | 8 | 2021 |
| Data evaluating triamcinolone acetonide and triamcinolone hexacetonide loaded poly (δ-valerolactone-co-allyl-δ-valerolactone) microparticles Z Bao, S Jung, J Bufton, P Bannigan, DJ Aguiar, C Allen Data in Brief 48, 109032, 2023 | 2 | 2023 |
| Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drug S Jung, J Bufton, Z Bao, W Cho, D Aguiar, C Allen Data in Brief 58, 111182, 2025 | | 2025 |
| Bench-Scale Microfluidic Manufacturing of Cross-Linked Polyester Microparticles JR Bufton, DC Burns, J Watchorn, S Lee, C Allen ACS Applied Polymer Materials 6 (16), 10049-10061, 2024 | | 2024 |
